For the first time in India's history, the Union Budget allocated over Rs 1 lakh crore to health and family welfare — Rs 1,02,000 crore in FY27 versus Rs 88,000 crore in FY26 — reflecting a significant policy commitment to addressing India's chronic underinvestment in public healthcare infrastructure that has left hundreds of millions of Indians dependent on poorly regulated and often unaffordable private healthcare. The Health Ministry received the fourth-largest ministry allocation after Defence, Rural Development and Roads, signaling its elevated priority in the government's budget calculus ahead of what is expected to be a politically sensitive electoral cycle where health access is a top voter concern.
The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana received Rs 12,000 crore — a 44% increase over FY26 — to fund the expansion of coverage from the existing 55 crore beneficiaries to 75 crore individuals through the inclusion of MSME workers, gig economy participants and people aged 70+ (all income groups), the latter being the most significant new group added under the "Ayushman Vayo Vandana" extension announced in the budget speech. The coverage expansion to senior citizens regardless of income is a politically popular inclusion that addresses the severe vulnerability of older Indians who face the highest healthcare costs and are least able to absorb unexpected medical expenses, often depleting lifetime savings on end-of-life care for major conditions including cancer, cardiac disease and kidney failure.
Medical education infrastructure received a major boost with the announcement of 10 new AIIMS (All India Institute of Medical Sciences) across 10 underserved states including Bihar, Jharkhand, Manipur, Meghalaya, Nagaland, Mizoram, Tripura, Himachal Pradesh, Jammu and Ladakh, in addition to upgradation of 50 district hospitals to teaching hospitals with attached medical colleges that will dramatically increase India's medical graduate output from the current 70,000 annually to a projected 1.4 lakh by 2030. The shortage of doctors — India has 1 doctor per 1,200 population against the WHO recommendation of 1 per 1,000 — is the most binding constraint on India's primary healthcare capacity, and increasing medical graduate production is the most direct long-term solution, even if the benefits take a decade to fully materialise.
Mental health was given unprecedented policy visibility in Budget 2026, with a dedicated National Mental Health Mission announcement with an Rs 8,000 crore five-year outlay covering community mental health centres in every district headquarter, school-based mental health screening and support programmes in government schools, tele-mental health services integrated with the Ayushman Bharat digital health mission, and training of 2 lakh ASHA and anganwadi workers in mental health first aid. The mission acknowledges the long-hidden scale of India's mental health burden — 150 million individuals estimated to need mental health care — and the near-total absence of accessible, affordable mental health services in non-metro areas where psychiatrists and psychologists are vanishingly rare.
The pharmaceutical and medical devices sectors received targeted budget support through a Rs 4,000 crore Medical Devices PLI extension and a Rs 3,500 crore Bulk Drug Parks programme that will establish domestic manufacturing capacity for 53 critical active pharmaceutical ingredients currently imported entirely from China, including antibiotics, vitamins and paracetamol. The COVID-19 pandemic exposed India's vulnerability in API supply chains and accelerated the government's resolve to achieve self-sufficiency in key pharmaceutical ingredients — a strategic imperative that aligns commercial and security interests. The domestic medical devices PLI, targeting categories including cardiac stents, orthopaedic implants, MRI machines, CT scanners and diagnostic kits, aims to reduce India's $3 billion annual medical devices import bill while creating a new high-technology manufacturing sector that can eventually compete in global export markets.